5a ) and a more unfavorable progression-free survival rate with marginal significance ( Fig. 5b ).
← all excerpts
PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs.
1
—
—
5a ) and a more unfavorable progression-free survival rate with marginal significance ( Fig. 5b ).